SciELO - Scientific Electronic Library Online

 
vol.44 issue1HIV and risk behaviors of persons of low socio-economic status, Popayan-Colombia (2008-2009)Genetic variants associated with addictive behavior in Colombian addicted and non-addicted to heroin or cocaine author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Colombia Médica

On-line version ISSN 1657-9534

Abstract

MACHADO-ALBA, Jorge et al. Prescribing patterns and economic costs of proton pump inhibitors in Colombia. Colomb. Med. [online]. 2013, vol.44, n.1, pp.13-18. ISSN 1657-9534.

Objective: To determine the prescribing patterns for proton pump inhibitors and to estimate the economic cost of their use in a group of patients affiliated with the Colombian Health System. Methods: This is a descriptive observational study. Data for analysis consisted of prescriptions dispensed between October 1st, 2010 and October 31st, 2010 and were collected from a systematic database of 4.2 million members. Socio-demographic variables were considered along with the defined daily dose,comedication, convenience of the indication for proton pump inhibitor use and costs. Results: In this study, 113,560 prescriptions were dispensed in 89 cities, mostly to women (57.6%) with a mean age of 54.4 ± 18.7 years; the drugs were omeprazole (n=111,294; 97.81%),esomeprazole (n=1,378; 1.2%), lansoprazole (n=524; 0.4%), pantoprazole and rabeprazole. The indication for 87,349 of the formulas (76.9%) was justified and statistically associated with the use of NSAIDs, antithrombotics, corticosteroids, anti-ulcer, antibiotics and prokinetics. No justification was found for 26,211 (23.1%) of the prescriptions, which were associated with antidiabetics, antihypertensives, hypolipidemics and others (p 0.001).The annual justified cost was estimated to be US$ 1,654,701 and the unjustified cost was estimated to be U.S. $2,202,590, as calculated using the minimum reference prices.

Keywords : Health care costs; drug costs; pharmaceutical services; omeprazole; esomeprazole; lanzoprazole.

        · abstract in Spanish     · text in English     · English ( pdf )